Unique ID issued by UMIN | UMIN000034518 |
---|---|
Receipt number | R000039357 |
Scientific Title | A study |
Date of disclosure of the study information | 2018/10/16 |
Last modified on | 2019/10/17 09:49:40 |
A study
A study
A study
A study
Japan |
None
Not applicable | Adult |
Others
NO
To evaluate for reduction of body fat mass including visceral fat and for safety when supplementation with food containing ingredients of plant origin for 12 weeks for healthy adult men and women with BMI of 23.0 kg/m2
Safety,Efficacy
Abdominal visceral fat area
Abdominal subcutaneous fat area, abdominal total fat area, waist circumference
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
NO
NO
Central registration
2
Prevention
Food |
Take two capsules of the test food orally at dinner for 12 weeks
Take two capsules of the placebo food orally at dinner for 12 weeks
20 | years-old | <= |
65 | years-old | > |
Male and Female
1) Japanese males and females aged of 20-64 years.
2) Subjects whose BMI values are 23.0 or more and less than 30.0.
3) Subjects who can visit the hospital/clinic on the scheduled visit date
4)Subjects who agreed in writing prior to the start of the trial with sufficient understanding of the purpose and contents of this study
1) Subjects who are under treatment or have a history of serious liver damage/disease, kidney disease, heart disease, lung disease, gastrointestinal disease (including gastrectomy), other severe disorders, or diabetes
2) Subjects who are under treatment (Excluding transient treatment such as common cold)
3) Subjects who cannot maintain their own life-style
4) Subjects who plan to travel overseas or have a long business trip during this study period
5) Subjects who are shift workers or graveyard shift workers
6) Subjects who use oral medication or supplements which may affect this study
7) Subjects drink alcohol over 1,000mL in terms of beer (= 40 mL of pure alcohol) per day
8) Subjects smoke over average 20 cigarettes per day
9) Subjects who are pregnant, lactation, or planning to become pregnant
10) Subjects who are sensitive to test product or other foods, and medical products.
11) Subjects who cannot take the test food as instructed
12) Subjects who donated blood component or more than 200 mL of whole blood from the last one month just before the start of the study
13) Subjects who have experienced sickness due to blood collection
14) Subjects in constipation (frequency of defecation twice or less a week, feces is hard, difficulty of defecation, feeling of remaining feces)
15) Subjects who participated in other clinical studies in the past 3 months
16) Subjects who have some metal inside the body
17) Subjects judged as unsuitable for this study by the principal investigator
200
1st name | |
Middle name | |
Last name | tomita shinpei |
NDRC
clinical
452-1
0123-34-0412
s-tomita@ndrcenter.co.jp
1st name | |
Middle name | |
Last name | Toyotada Ashino |
New drug research center, Inc.
Clinical Research Dept.
452-1Toiso,Eniwa-shi,Hokkaido, Japan
0123-34-0412
t-ashino@ndrcenter.co.jp
New drug research center, Inc.
NDRC
Profit organization
NO
福原医院(北海道)
2018 | Year | 10 | Month | 16 | Day |
Unpublished
Completed
2018 | Year | 10 | Month | 16 | Day |
2018 | Year | 10 | Month | 16 | Day |
2019 | Year | 01 | Month | 04 | Day |
2019 | Year | 05 | Month | 18 | Day |
2018 | Year | 10 | Month | 16 | Day |
2019 | Year | 10 | Month | 17 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039357